Add BrightSurf on Google Email

RNA therapy may help preserve muscle during GLP-1 weight loss

A new RNA therapy promotes thermogenesis, turning white fat into beige fat that burns energy, and preserves lean muscle mass when combined with GLP-1s. This treatment improves glucose tolerance and other measures of metabolic health, offering a potential solution to the loss of muscle mass associated with GLP-1 weight loss.

SourceNorthwestern University·JournalProceedings of the National Academy of Sciences·DateSep 21, 2026

Autism-risk mutations reveal two opposing patterns of brain gene activity

Researchers identified two opposing patterns of brain gene activity in mice carrying autism-risk mutations, which vary by sex and respond differently to experimental drugs. The patterns, which are shared across multiple analyses, suggest that many different genetic mutations converge into a limited number of molecular brain states.

SourceInstitute for Basic Science·JournalScience·TypeExperimental study·DateSep 17, 2026

Thousands of new findings contribute to a global virus map

A global virus atlas has been created by mapping RNA viruses in 102 cities worldwide, identifying nearly 55,000 different types, 80% of which were unknown to science. This data can be used for biological risk assessment, crime scene investigations, and environmental monitoring, providing a unique viral fingerprint for each location.

SourceLund University·JournalNature Communications·DateSep 9, 2026

AI-designed proteins enable a new generation of RNA transporters

Researchers at Helmholtz Munich developed Synthetic Transfer Vehicles (STVs), an entirely new class of RNA transporters. STV-C8 is the most efficient candidate, transporting RNA far more efficiently than traditional lipid nanoparticles. In animal models, STV-C8 demonstrates effective delivery and expression of RNA in a living organism.

A Google-like search engine for single-cell RNA

Researchers at the Max Delbrück Center have developed a search engine, Malva, to analyze single-cell RNA data, enabling rapid analysis of millions of cells worldwide. Malva simplifies the task of wading through data from thousands of experiments and provides insights into RNA biology, cancer, and disease mechanisms.

SourceMax Delbrück Center for Molecular Medicine in the Helmholtz Association·JournalNature·TypeData/statistical analysis·DateAug 28, 2026

mRNA immunotherapy developed by UMass Chan scientists eliminates pancreatic tumors in mice

Researchers have developed an mRNA immunotherapy that eliminates pancreatic tumors in mice, achieving complete tumor responses and long-term disease-free periods. The treatment uses a cocktail of immune cytokine and tumor-associated antigen mRNAs, showing promise as a potential transformative treatment for pancreatic cancer.

SourceUMass Chan Medical School·JournalNature Communications·TypeExperimental study·DateAug 25, 2026

A new study reveals how the brain helps protect fertility from heat-induced damage

A new study reveals that the brain plays a crucial role in protecting fertility during heat stress by sending signals to reproductive cells. Researchers discovered an unexpected communication system between the brain and germline cells, showing how animals adjust reproduction when conditions become unfavorable.

SourceThe Hebrew University of Jerusalem·JournalCurrent Biology·TypeExperimental study·DateAug 2, 2026

Scientists at UMass Chan Medical School develop microRNA-based gene therapy that halts ALS progression in mice

Researchers at UMass Chan Medical School have developed a microRNA-based gene therapy that suppresses mutant SOD1 production, delaying disease onset by 60 days and extending lifespan by 100 days in mice models of ALS. The therapy, delivered via adeno-associated virus (AAV) vector, preserves motor neurons and maintains neuromuscular con...

SourceUMass Chan Medical School·JournalNature Communications·TypeExperimental study·DateJul 29, 2026

Researchers show how early RNA-based life may have repaired its genome, providing insight into the origins of life

Scientists engineered an enzyme that selectively recognizes and repairs broken RNA, suggesting that molecular tools needed to preserve the RNA-based genetic code could be furnished by RNA alone. This discovery has implications for understanding the origins of life and developing new biotechnology applications.

SourceUniversity of Notre Dame·JournalNature Communications·DateJul 13, 2026

New therapy may reverse autism-related brain deficits

Researchers identified a promising new strategy for reversing autism-related brain deficits by targeting a specific glycine transporter. The therapy restored NMDA receptor function in mouse models and human brain organoids, improving behavioral abnormalities such as social interaction and repetitive behaviors.

SourceInstitute for Basic Science·JournalNature Communications·TypeExperimental study·DateJun 9, 2026

RNA therapy as a novel treatment strategy for genetic heart failure

Researchers used RNA therapy to target a genetic mutation causing heart failure, reducing protein aggregation and improving cellular abnormalities. The study provides insight into the biological mechanisms underlying treatment response and may accelerate the development of personalized treatments for genetic heart disease.

SourceUniversitair Medisch Centrum Groningen·JournalSignal Transduction and Targeted Therapy·TypeExperimental study·DateMay 29, 2026

A*STAR scientists develop new method to reveal how RNA structure influences health and disease

Researchers developed a new method called sm-PORE-cupine to study individual RNA molecules and reveal how their structures influence gene regulation. The technology provides deeper insight into how RNA structure affects cellular function and could help identify new therapeutic targets for diseases such as viral infections.

Hidden small RNA determines if cholera bacterium can infect humans

Scientists at St. Jude Children's Research Hospital have identified a small RNA embedded within the V. cholerae gene as the key factor controlling its ability to infect humans. Variations in this RNA controlled about 85% of genes related to human infection, enabling the bacteria to evade immune barriers and colonize the gut.

SourceSt. Jude Children's Research Hospital·JournalNature Communications·TypeExperimental study·DateMay 14, 2026

DNA matches identify four more sailors from Franklin expedition

Researchers from the University of Waterloo have identified four more members of Sir John Franklin's 1845 expedition using DNA samples extracted from skeletal remains. The new discoveries bring the total number of identified sailors to six, providing previously unavailable details about the circumstances and locations of their deaths.

SourceUniversity of Waterloo·JournalJournal of Archaeological Science Reports·TypeExperimental study·DateMay 6, 2026

The boy on the balcony who never came outside

Dr. Dilek Colak's journey began with a childhood observation of a boy with mental illness, which inspired her to pursue a career in neuroscience. Her current work focuses on understanding autism and schizophrenia through the study of human brain organoids.

SourceGenomic Press·JournalGenomic Psychiatry·TypeNews article·DateMay 5, 2026

Point-of-care hepatitis C testing in a tribal setting

A community-based point-of-care HCV RNA testing program was feasible and led to a high percentage of same-day treatment for American Indian and Alaska Native participants. The study supports expanding point-of-care HCV RNA testing and integrated treatment to advance HCV elimination.

SourceJAMA Network·JournalJAMA Network Open·DateApr 15, 2026

Scientists reverse brain aging, with a nasal spray

Researchers developed a nasal spray that reversibly reduces brain inflammation, restores cellular power plants, and improves memory. The treatment bypasses the brain's protective shield through intranasal delivery, suppressing chronic inflammation and promoting successful brain aging.

SourceTexas A&M University·JournalJournal of Extracellular Vesicles·DateApr 14, 2026

Scientists identify dysregulation of RNA editing as contributor to altered fetal brain development in down syndrome

Researchers found that an extra copy of chromosome 21 leads to increased levels of the ADARB1 enzyme, causing premature and excessive RNA editing in developing brain cells. This dysregulation affects how brain cells communicate and form circuits, potentially influencing neurological and behavioral outcomes in Down syndrome.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNature Communications·TypeObservational study·DateMar 31, 2026